The Bell Potter Healthcare Conference will be held on 17, 18 and 19 November 2026, from 8.30am to 5.00pm (AEDT).

Global investor sentiment towards biotechnology has strengthened materially during 2026, with major US biotechnology indices trading back towards record levels and capital returning to innovative healthcare companies. M&A has also accelerated as major pharmaceutical companies seek to replenish their pipelines ahead of approaching patent cliffs. This improving global backdrop provides a positive lead for ASX healthcare, with scope for investor sentiment and capital flows to strengthen as the recovery broadens.

The conference will showcase leading and emerging ASX-listed companies across biotechnology, medical devices, healthcare software and diagnostics. Participants will hear business updates, growth strategies and upcoming clinical, regulatory and commercial catalysts, followed by opportunities for Q&A. Supported by Bell Potter’s deep healthcare expertise across research and capital markets, the conference provides a timely opportunity to connect with companies positioned to benefit from the sector’s next phase of growth.